Company Filing History:
Years Active: 2002-2004
Title: Anne M Crompton: Innovator in Predictive Cellular Bioinformatics
Introduction
Anne M Crompton is a prominent inventor based in San Francisco, CA (US). She has made significant contributions to the field of bioinformatics, particularly in the development of systems that enhance our understanding of cellular information. With a total of 6 patents to her name, Crompton's work is at the forefront of innovation in predictive cellular analysis.
Latest Patents
One of her latest patents is a database system for predictive cellular bioinformatics. This system is designed to acquire knowledge from cellular information and includes a database management module (DBMS). It features various modules, including a population module that categorizes and stores multiple features such as cell size, distance between cells, cell population, and cell type from an image acquisition device. Additionally, the system has a translation module that defines a descriptor from a selected set of features. This descriptor can pertain to known or unknown compounds, such as drugs. A prediction module is also integrated, which selects descriptors from known and unknown compounds based on a selected descriptor from a chosen compound. This innovative system has the potential to identify compounds useful for the treatment of human beings.
Career Highlights
Throughout her career, Anne M Crompton has worked with notable companies, including Cytokinetics, Inc. and Onyx Pharmaceuticals, Inc. Her experience in these organizations has allowed her to develop and refine her innovative ideas in the field of bioinformatics.
Collaborations
Crompton has collaborated with esteemed colleagues, including James H Sabry and Cynthia L Adams. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Anne M Crompton is a trailblazer in the realm of predictive cellular bioinformatics, with a strong portfolio of patents and a career marked by significant contributions to the field. Her innovative work continues to pave the way for advancements in cellular analysis and treatment options.